Quick Connect Send a message
Certificate of Suitability (CEP) for the API Levofloxacin Hemihydrate has been granted.
Dr. Reddy’s is among the first companies to receive the CEP from the European Directorate for the Quality of Medicines (EDQM). Together with our expanded manufacturing capacities, this makes us a reliable partner to support your oral and injectable formulations of this anti-infective.
Reach out to our API team at [email protected] or submit an enquiry below to learn more.
Find out more about the product here:
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.
+91 4049002253